abstract |
It relates to use of nicotinamide mononucleotide, in particular, relates to use of nicotinamide mononucleotide for the preparation of a medicament for preventing or alleviating liver injury or liver fibrosis in a subject, and a method for preventing liver injury or liver fibrosis in a subject. It also relates to a method of producing dihydronicotinamide mononucleotide (NMNH) and uses of NMNH. |